PSMA-IN-3 (compound 17) is a novel high-affinity PSMA inhibitor with an IC 50 value of 13 nM. PSMA-IN-3 is suitable for developing an 18 F-labeled radioligand for PET imaging of PSMA in prostate cancer .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > PSMA
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.